Strata Critical Medical Announces Expiration of Warrants

(High)

(Neutral)

Rhea-AI Summary

Strata Critical Medical (Nasdaq: SRTA) announced that its Public Warrants (Nasdaq: SRTAW) and Private Placement Warrants expired at 5:00 p.m. Eastern Time on May 7, 2026 in accordance with their original terms. The expiration was announced by the company on that date.

News Market Reaction – SRTA

+4.31%

3 alerts

+4.31% Session close to close

-7.7% Trough Tracked

$485.41M Market Cap

0.2x Rel. Volume

In the May 8 session, SRTA gained 4.31%, reflecting a moderate positive market reaction. Argus tracked a trough of -7.7% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement centers on the expiration of Strata Critical Medical’s public and private placemen...

Analysis

This announcement centers on the expiration of Strata Critical Medical’s public and private placement warrants according to their original terms at 5:00 p.m. Eastern Time on May 7, 2026. It follows a series of strong earnings reports and a recent bolt-on acquisition that supported revenue and EBITDA growth. Investors may monitor how the simplified capital structure and subsequent updates to guidance or deal activity influence future results.

Historical Context

5 past events · Latest: May 06 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 06	Earnings results	Positive	+10.6%	Strong Q1 2026 growth, positive net income and reiterated 2026 guidance.
Apr 30	M&A acquisition	Positive	+1.2%	Acquisition of Ohio Valley Perfusion Associates to expand perfusion services.
Apr 20	Earnings call setup	Neutral	+6.0%	Scheduling Q1 2026 earnings release and conference call details.
Apr 09	Conference presentation	Neutral	-0.3%	Announcement of presentation at Needham Virtual Healthcare Conference.
Mar 03	Earnings results	Positive	+6.9%	Q4 2025 and FY2025 results with raised 2026 guidance and strong EBITDA.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent operational and earnings updates have generally aligned with positive price reactions, while neutral event headlines occasionally coincide with disproportionate upside moves.

Recent Company History

Over the past several months, Strata Critical Medical has reported strong growth and improved profitability metrics. Q4 2025 revenue was $66.8M with FY2025 revenue of $197.1M, and 2026 revenue guidance was raised to $260–$275M with Adjusted EBITDA of $29–$33M. Q1 2026 results showed revenue of $67.4M and Adjusted EBITDA of $6.4M, alongside a bolt-on perfusion acquisition for about $1M. The current warrant expiration follows a series of fundamentally focused, growth-oriented updates that have previously been met with positive price reactions.

Key Terms

public warrants, private placement warrants

2 terms

public warrants financial

"its warrants, both the Public Warrants (Nasdaq: SRTAW) and the Private"

Public warrants are tradable securities that give the holder the right to buy a company’s stock at a fixed price before a set expiration date. Like a coupon that lets you purchase shares later at a preset price, they matter to investors because using them can bring new cash into the company but also increase the total number of shares outstanding, which can dilute existing ownership and influence the stock’s price and potential gains.

private placement warrants financial

"Public Warrants (Nasdaq: SRTAW) and the Private Placement Warrants, expired"

Private placement warrants are tradable coupons given directly to a limited group of investors that let the holder buy a company's shares at a fixed price before a set expiration date. They matter to investors because they can provide extra upside if the stock rises and give companies a way to raise money outside a public offering, but they also can increase the number of shares outstanding (dilution) and therefore affect share value and investor returns.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

05/07/2026 - 05:05 PM

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), announced that its warrants, both the Public Warrants (Nasdaq: SRTAW) and the Private Placement Warrants, expired in accordance with their original terms at 5:00 p.m. Eastern Time today May 7, 2026.

About Strata Critical Medical, Inc.

Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.

Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.

For more information, visit www.srta.com.

Contacts

Mathew Schneider
investors@srta.com

FAQ

What happened to Strata Critical Medical warrants (SRTAW) on May 7, 2026?

The warrants expired at 5:00 p.m. Eastern Time on May 7, 2026. According to Strata Critical Medical, both Public Warrants (Nasdaq: SRTAW) and Private Placement Warrants expired in accordance with their original terms.

Do expired Strata warrants (SRTAW) still trade after May 7, 2026?

No, the warrants ceased to be exercisable after expiration at 5:00 p.m. ET on May 7, 2026. According to Strata Critical Medical, both the Public and Private Placement Warrants expired under their original contractual terms.

Will Strata (SRTA) issue replacement warrants after the May 7, 2026 expiration?

The company did not announce replacement warrants in the notice of expiration. According to Strata Critical Medical, the release only states that the existing Public and Private Placement Warrants expired per their original terms.

How does the warrant expiration affect SRTA shareholders or warrant holders?

Holders lost the right to exercise those warrants after 5:00 p.m. ET on May 7, 2026. According to Strata Critical Medical, the expiration occurred under the warrants' original terms, with no additional actions disclosed.

Where can investors verify the May 7, 2026 warrant expiration for SRTA?

Investors can confirm the expiration through the company's official disclosures and Nasdaq listings. According to Strata Critical Medical, the Public Warrants (Nasdaq: SRTAW) and Private Placement Warrants expired at 5:00 p.m. Eastern Time on May 7, 2026.